Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis Bronchiectasis
Clinical trial NCT01314716 · COMPLETED
Trial details
- NCT number
- NCT01314716
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2013-04-01
- Enrollment
- 274
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.